Andra AP-fonden’s NovoCure NVCR Stock Holding History

Andra AP-fonden’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,200	Closed	-$253K	–	595
2023 Q1	$253K	Buy	+4,200	New	+$336K	0.01%	555
2021 Q3	–	Sell	-1,300	Closed	-$288K	–	606
2021 Q2	$288K	Sell	1,300 -2,800	-68%	-$545K	0.01%	594
2021 Q1	$542K	Sell	4,100 -1,000	-20%	-$158K	0.01%	578
2020 Q4	$883K	Buy	+5,100	New	+$698K	0.02%	583

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return

Andra AP-fonden's NVCR Position: Q2 2023 in Review

Andra AP-fonden sold out of NovoCure (NVCR) in Q2 2023, closing a stake of 4,200 shares — an estimated $253K sold.

Andra AP-fonden first reported a position in NVCR in Q4 2020 and held it in 4 quarters. The position peaked at $883K in Q4 2020. 267 funds tracked by Wall St. Rank hold NVCR as of Q2 2023.

Andra AP-fonden reported no remaining NovoCure position as of Q2 2023 after selling out during the quarter.
Andra AP-fonden sold 4,200 NovoCure shares in Q2 2023, an estimated $253K.
Andra AP-fonden first reported a position in NovoCure in Q4 2020 and held it in 4 quarters.
Andra AP-fonden's NovoCure position peaked at $883K in Q4 2020.
267 funds tracked by Wall St. Rank held NovoCure as of Q2 2023.

Based on Andra AP-fonden's 13F filing for Q2 2023, filed 9 Aug 2023.